FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following...
0001802768December 312022Q2FALSE00018027682022-01-012022-06-300001802768us-gaap:CommonClassAMember2022-08-01xbrli:shares0001802768us-gaap:CommonCla...
0001802768false00018027682022-08-042022-08-04UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant...
Strong growth in net cash provided by operating activities and Adjusted Cash Receipts(1)Announced transactions of up to $2.5 billion year-to-date...
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has...
NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will...
NY false 0001802768 0001802768 2022-07-13 2022-07-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.